BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6595184)

  • 21. [Priming with intracervically administered prostaglandin F2 alpha before abortion].
    Gstöttner H; Richter H; Rothe K
    Zentralbl Gynakol; 1979; 101(6):404-8. PubMed ID: 452760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Side effects and early complications following cervical priming with prostaglandin F2 alpha (PGF2 alpha) in inducing abortion in young women in their 1st pregnancy].
    Seifert B; Martin K
    Zentralbl Gynakol; 1983; 105(11):710-4. PubMed ID: 6576539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficiency and complication rate of intracervical prostaglandin F2 alpha administration for induced abortion].
    Hölzel D; Berle P
    Arch Gynecol; 1979 Jul; 228(1-4):412-3. PubMed ID: 485399
    [No Abstract]   [Full Text] [Related]  

  • 24. [The induction of abortion and the priming of the cervix with prostaglandin F2 alpha and prostaglandin E2 by intra-amniotic, extra-amniotic and intra-cervical application (author's transl)].
    Schmidt W; Widmaier G; Ditz S; Kubli F
    Geburtshilfe Frauenheilkd; 1982 Feb; 42(2):118-22. PubMed ID: 6917804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of low-dose 15-methyl prostaglandin F2 alpha for cervical ripening in the first trimester of pregnancy.
    Arias F
    Am J Obstet Gynecol; 1984 May; 149(1):100-1. PubMed ID: 6720761
    [No Abstract]   [Full Text] [Related]  

  • 26. Preoperative cervical dilatation by small doses of prostaglandin F 2 alpha.
    Andriesse R; Hart H; Haspels AA
    Contraception; 1976 Jul; 14(1):93-9. PubMed ID: 975815
    [No Abstract]   [Full Text] [Related]  

  • 27. [Local application of prostaglandin F2 alpha to primigravid interruption patients in first trimester].
    Heinz M; Günther H; Pundrich C
    Zentralbl Gynakol; 1982; 104(13):784-90. PubMed ID: 6958145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of abortion using prostaglandins.
    Schultz RH; Copeland DD
    Acta Vet Scand Suppl; 1981; 77():353-61. PubMed ID: 7030032
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience from direct injection of low prostaglandin F2alpha doses into portio for low-complication dilatation of cervix for abruptio (author's transl)].
    Voigt R; Sommer H; Fritzsche H; Seewald HJ
    Zentralbl Gynakol; 1979; 101(24):1592-4. PubMed ID: 547612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Maturation of the cervix by prostaglandins before inducing termination of pregnancy, in the first trimester (author's transl)].
    Bourrit B; Raymond L; Wyss R; Béguin F
    J Gynecol Obstet Biol Reprod (Paris); 1979; 8(6):567-70. PubMed ID: 548558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extraovular prostaglandin F2 alpha as an abortifacient in early midtrimester pregnancy.
    Robins J; Mitler L; Pollack L; Mann LI
    Adv Plan Parent; 1975; 10(1):39-44. PubMed ID: 1164987
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuous extraovular prostaglandin F2 alpha instillation for second-trimester pregnancy termination.
    Atad J; Lissak A; Sorokin Y; Bornstein J; Auslender R; Rofe A; Abramovici H
    Isr J Med Sci; 1985 Dec; 21(12):935-9. PubMed ID: 3867655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extraovular midtrimester abortion by prostaglandin impact.
    Schulman H; Saldana LR; Yang W; Leibman T; Cunningham M; Randolph G
    Adv Plan Parent; 1975; 9(3-4):45-51. PubMed ID: 1164996
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of prostaglandins in gynecology and obstetrics and outlook on the second generation of prostaglandins].
    Wiqvist N
    Gynakol Rundsch; 1978; 18 Suppl 1():1-8. PubMed ID: 570142
    [No Abstract]   [Full Text] [Related]  

  • 35. The A-rod--a new possibility for cervical dilation and/or induction of uterine contractions for abortion or delivery by combined pharmacological and mechanical action.
    Brundin J; Christensen NJ; Fuchs T; Larsson M
    Acta Obstet Gynecol Scand Suppl; 1983; 113():159-62. PubMed ID: 6574673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local prostaglandin F2 alpha injection for termination of ectopic pregnancy.
    Lindblom B; Hahlin M; Källfelt B; Hamberger L
    Lancet; 1987 Apr; 1(8536):776-7. PubMed ID: 2882185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Induction of abortion during the 2d pregnancy trimester by intra-amniotic administration of PGF2 alpha].
    Pajor A; Bakos L; Zsolnai B
    Orv Hetil; 1983 Jul; 124(28):1671-4. PubMed ID: 6577382
    [No Abstract]   [Full Text] [Related]  

  • 38. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
    Lauersen NH; Graves ZR
    J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dilating effect of prostaglandin F2 alpha on the cervix uteri].
    Paĭor A; Kazi Z; Garambelli D; Shikloshi D
    Akush Ginekol (Mosk); 1989 May; (5):67-8. PubMed ID: 2742077
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effectiveness and side-effects of intracervical application of prostaglandin F2-alpha-gel in the early weeks of pregnancy (author's transl)].
    Neeb U
    Geburtshilfe Frauenheilkd; 1980 Oct; 40(10):901-3. PubMed ID: 7439645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.